相关实验视频
Updated: Sep 17, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
在 doxorubicin 诱导的心脏毒性的 PCSK9 的功能及其潜在机制
Shuai Shi1,2, Zhihui Qin3, Chang Liu4
1Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. shishuai@hrbmu.edu.cn.
Scientific reports
|July 2, 2025
概括
德克索鲁比化疗会通过增加PCSK9蛋白质引起心脏损伤. 像evolocumab这样的PCSK9抑制剂可以防止这种心脏毒性,这表明了新的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多克索鲁比 (DOX) 化疗受心脏毒性限制.
- 蛋白转化酶亚提利辛/凯类型9 (PCSK9) 与心血管疾病有关.
- PCSK9和DOX诱导的心脏毒性 (DIC) 之间的关系尚未被探索.
研究的目的:
- 调查PCSK9在DOX诱导心脏毒性的作用.
- 探索PCSK9抑制对DIC.的治疗潜力.
主要方法:
- 在小鼠中使用DOX诱导心脏毒性.
- 在心肌组织和H9C2细胞中分析了PCSK9表达及其与KPNB1的相互作用.
- 使用PCSK9抑制剂Evolocumab来评估其保护作用.
主要成果:
- DOX治疗增加了心脏中的PCSK9表达.
- 在DOX治疗小鼠中,Evolocumab的使用改善了心脏功能,并减少了心肌损伤和纤维化.
- 通过影响Bax/Bcl-2和Cleaved Caspase-3/Pro Caspase-3比率并调节KPNB1.1,抑制PCSK9调节心肌细胞亡.
结论:
- PCSK9在DOX诱导的心脏毒性中发挥着重要作用.
- 抑制PCSK9显示出对DOX诱导的心脏毒性的保护作用.
- 向PCSK9可能是减轻化疗相关心脏损伤的新疗法策略.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
Heart Failure Drugs: Inotropic Agents
743
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
743
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Coronary Artery Disease II: Pathophysiology
42
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
Mechanism of Cardiac Arrhythmias
1.1K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K

